Metallothionein (MT) and glutathione (GSH) have been implicated as two major copper-binding agents involved in the hepatobiliary copper metabolism in the adult rat. This study was designed to explore their potential role in facilitating copper export from the copper-laden hepatocyte of the newborn r
Strain-related patterns of biliary excretion and hepatic distribution of copper in the rat
โ Scribed by Hubertus Nederbragt; Aart J. Lagerwerf
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 775 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Biliary copper excretion was studied in male, bilecannulated rats of the inbred strains Fischer, Brown Norway, WAG/Rij and Lewis. After intravenous injection of 10,30 and 60 pg copper per 100 gm body weight, two patterns of copper excretion were observed; their profiles varied with the copper dose and the strain of the rats used. The lowest amounts of copper were excreted by Fischer rats, the highest by WAG/Rij rats; this was related to the effect of the copper dose on both patterns. The subcellular distribution of copper in the liver was studied in Fischer and Brown Norway rats after doses of 60, 100, and 200 pg per 100 gm body weight. Brown Norway rats accumulated more copper in the liver, although the copper concentration was the same in both strains 1 hr after injection of all doses. Fischer rats accumulated proportionally more copper in lysoeomal and nuclear mitochondrial fractions whereas Brown Norway rats accumulated proportionally more copper in the cytosol.
Gel filtration of liver supernatants revealed that the amount of copper accumulating in the protein presumed to be metallothionein was 2 to 3 times higher in Brown Norway rats, whereas in the Fischer rats more copper eluted in the void volume fraction. We conclude that both biliary copper excretion and copper distribution in the liver are under genetic control. Because of its low copper excretion and reduced binding of copper to me- tallothionein the Fischer rat, compared to other strains, may be a suitable model for studying the involvement of the liver in copper intoxication.
In the liver, two distinct mechanisms are present that may prevent incoming copper (Cu) from becoming toxic. The first mechanism is the excretion of Cu into the bile which, under normal conditions, is the main route of Cu excretion (1). The second mechanism is the binding of Cu to metallothionein (MT), a sulfhydryl-rich protein of low molecular weight that is able to bind other metals as well; the synthesis of MT is induced by the presence of Cu in the cell (2).
Somehow, these mechanisms may fail, and this may lead to accumulation of Cu in the liver and to accom-
๐ SIMILAR VOLUMES
Irinotecan (CPT-11) is a semisynthetic derivative of camptothecine that has proved activity in the treatment of colorectal carcinoma. The metabolites identiยฎed in humans include SN-38, SN-38 glucuronide, and several CYP3A-derived metabolites. We have studied the hepatic extraction, metabolism, and b
The disappearance from plasma and the excretion in bile of the monoquaternary thiazinamium (administered as the iodide) and one of its polar metabolites, thiazinamium sulfoxide (also administered as the iodide), were studied in the rat after intravenous injection to obtain more information on hepati
Endotoxin is known to cause a dose-dependent impairment of hepatic bile secretion, organic anion excretion, and activity of Na+,K'-activated ATPase. Since it is possible that this impaired excretory function is a result of direct interaction of endotoxin with hepatocytes, we examined: (a) the excret